Table 3.

Investigations, treatment, and outcome measures

Variables	Categories	n (%)
CSF protein (mg/dl)	45 and less	3 (12)
	More than 45	22 (88)
CSF WBC	0–5	23 (92)
	10	2 (8)
NCS	Predominantly Axonal	9 (36)
	Predominantly Demyelinating	7 (28)
	Mixed	5 (20)
	Normal	4 (16)
Treatment	IVIG	28 (93.3)
	Plasma exchange	1 (3.3)
	Observation	1 (3.3)
Length of hospital stay	1–7 days	13 (43.3)
	8–14 days	13 (43.3)
	>14 days	4 (13.3)
ICU admission	Yes	11 (36.7)
	No	19 (63.3)
Intubation	Yes	2 (6.7)
	No	28 (93.3)
Outcome at discharge (GBS disability score)	0 Healthy	0
	1 Minor symptoms and signs, able to run	5 (16.7)
	2 Able to walk 5 meters independently	4 (13.3)
	3 Able to walk 5 meters with a walker or support	7 (23.3)
	4 Bed or chair bound	14 (46.7)
	5 Requiring assisted ventilation for at least part of the day	0
	6 Death	0
Outcome on follow-up (GBS disability score)	0 Healthy	5 (20)
	1 Minor symptoms and signs, able to run	7 (28)
	2 Able to walk 5 meters independently	4 (16)
	3 Able to walk 5 meters with a walker or support	6 (24)
	4 Bed or chair bound	3 (12)
	5 Requiring assisted ventilation for at least part of the day	0
	6 Death	0
The interval between discharge and follow-up	3–29 days	15 (60)
	30 or more days	10 (40)